6.28
2.94%
-0.19
Biocryst Pharmaceuticals Inc. (BCRX) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Revenues |
7.68%
93.40
|
86.74 | 82.49 | 68.78 | 79.55 |
Cost Of Revenue |
41.67%
1.557
|
1.099 | 0.894 | 0.931 | 2.383 |
Gross Profit |
7.24%
91.84
|
85.64 | 81.60 | 67.85 | 77.16 |
Operating Expenses
|
37.87%
134.51
|
97.56 | 102.30 | 96.26 | 123.47 |
Interest Income/Expense |
10.10%
24.58
|
27.34 | 28.91 | 27.40 | 26.46 |
Benefits Costs and Expenses |
27.74%
156.56
|
122.56 | 157.08 | 121.44 | 151.01 |
Costs And Expenses |
37.91%
136.07
|
98.66 | 103.19 | 97.19 | 125.86 |
Operating Income/Loss |
257.94%
-42.67
|
-11.92 | -20.70 | -28.41 | -46.31 |
Income/Loss From Continuing Operations Before Tax |
76.34%
-63.16
|
-35.82 | -74.59 | -52.66 | -71.47 |
Income Tax Expense/Benefit |
533.64%
-1.431
|
0.33 | 0.74 | 0.671 | 0.076 |
Income/Loss From Continuing Operations After Tax |
70.77%
-61.73
|
-36.15 | -75.33 | -53.33 | -71.54 |
Net Income/Loss
|
70.77%
-61.73
|
-36.15 | -75.33 | -53.33 | -71.54 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98.36%
3.103
|
189.64 | 189.12 | 188.51 | 0.342 |
Diluted Average Shares |
98.36%
3.103
|
189.64 | 189.12 | 188.51 | 0.342 |
Basic Earnings Per Share |
63.16%
-0.31
|
-0.19 | -0.40 | -0.28 | -0.38 |
Diluted Earnings Per Share |
63.16%
-0.31
|
-0.19 | -0.40 | -0.28 | -0.38 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
大文字化:
|
ボリューム (24 時間):